Investor Presentaiton
SARS-COV-2 clinical trial started in Argentina
Investigator initiated trial at: Centro de educación médica e investigaciones clinicas
(CEMIC) Instituto Milstein-CONICET Buenos Aires, Capital Federal, Argentina
Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of
COVID-19 Disease in Health Personnel Dedicated to Patients Care With
COVID-19 Disease (CARR-COV-02)
Study Design
Study Type
Estimate Enrollment
Allocation
Intervention Model
Intervention Model Description
Masking
Primary Purpose
Official Title
Actual Study Start Date
Estimated Primary Completion Date
Estimated Study Completion Date
Interventional (Clinical Trial)
400 participants
Randomized
Parallel Assignment
Multicenter, randomized, double blind compared vs. placebo
Double (Participant, Investigator)
Prevention
Efficacy of a Nasal Spray Containing Iota-Carrageenan
in the Prophylaxis of COVID-19 (CARR-COV-02)
July 24, 2020
October 30, 2020
November 30, 2020
marino
med
Source: https://www.clinicaltrials.gov/ct2/show/NCT04521322.
80View entire presentation